vaccinia virus therapy (Thomas Jefferson)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namevaccinia virus therapy (Thomas Jefferson)

Drug Alias Namemelanoma vaccine (Thomas Jefferson University)bladder cancer vaccine (Thomas Jefferson University)bladder tumor vaccine (Thomas Jefferson University)vaccinia/GM-CSF recombinant (Thomas Jefferson)

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsUrinary Bladder NeoplasmsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesThomas Jefferson University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThomas Jefferson University

Active IndicationsN/A

Inactive IndicationsUrinary Bladder NeoplasmsMelanoma

Other Information

ATC CodeN/A